A spectrum of dominant acting mutations in human FGFR1 and FGFR2 causes rare congenital skeletal syndromes, such as Apert and Pfeiffer.6 However, no association between these syndromes and predisposition or resistance to diabetes and obesity has been reported. Here, FGFR2 is linked to diabetes mellitus.